Literature DB >> 3816877

[Experimental filariasis in Proechimys oris by Dipetalonema dessetae. 5. Effect of parasitism on metabolism of diethylcarbamazine].

F Kani, M C Dessalles, C Jacquot, G Mahuzier, P Gayral.   

Abstract

The metabolism of diethylcarbamazine (DEC) in healthy and filaria-infected Proechimys oris Rodents was investigated. DEC and 14C labelled DEC were orally administrated (100 mg/kg). The drug was quickly and intensively metabolised. About 90% of the dose administered was eliminated in the urine within 24 hours. Monodeethylation was the major pathway. The major urinary metabolites were ethylcarbamazine and its N-oxide. Traces of N methylpiperazine 2,5 dione and their N-oxide were also found. Elimination was faster in filarial than in healthy animals, but metabolites were the same.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816877     DOI: 10.1007/BF03189849

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  Metabolism and excretion of 14C-labelled diethylcarbamazine.

Authors:  D R BANGHAM
Journal:  Br J Pharmacol Chemother       Date:  1955-12

2.  [Experimental filariasis in Proechimys oris by Dipetalonema dessetae: 4. Effect of parasitism on protein and tissue binding of diethylcarbamazine].

Authors:  F Kani; C Jacquot; P Gayral
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Apr-Jun       Impact factor: 2.441

3.  Identification of a urinary metabolite of perazine as a piperazine-2,5-dione derivative.

Authors:  D Krauss; W Otting; U Breyer
Journal:  J Pharm Pharmacol       Date:  1969-12       Impact factor: 3.765

4.  Dealkylation and N-oxidation in the metabolism of i-diethylcarbamyl-4-methylpiperazine in the rat.

Authors:  J K Faulkner; K J Smith
Journal:  Xenobiotica       Date:  1972-01       Impact factor: 1.908

5.  The metabolism of i-diethylcarbamyl-4-methylpiperazine in the rat and the sheep.

Authors:  J K Faulkner; K J Smith
Journal:  Xenobiotica       Date:  1971 Jul-Oct       Impact factor: 1.908

6.  Experimental filariasis of Dipetalonema dessetae in Proechimys oris: 3. Effects of parasitism on the pharmacokinetics of diethylcarbamazine.

Authors:  F Kani; P Gayral; M C Pfaff-Dessales; G Mahuzier; C Jacquot; J L Auget
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

7.  Identification and quantification of diethylcarbamazine and diethylcarbamazine N-oxide in rat urine.

Authors:  G Edwards; S A Ward; A M Breckenridge; M L Orme
Journal:  Xenobiotica       Date:  1981-04       Impact factor: 1.908

8.  Metabolism of diethylcarbamazine in mammals.

Authors:  B Chandrasekaran; B C Harinath
Journal:  Indian J Exp Biol       Date:  1980-07       Impact factor: 0.818

9.  Diethylcarbamazine disposition in patients with onchocerciasis.

Authors:  G Edwards; K Awadzi; A M Breckenridge; H M Gilles; M L Orme; S A Ward
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

10.  [Dipetalonema dessetae in Proechimys oris. II. Evaluation of the model for pharmacologic investigations of antifilarial chemotherapy (author's transl)].

Authors:  P Gayral; G Dreyfuss; J C Gantier
Journal:  J Pharmacol       Date:  1982 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.